Nelfinavir Mesylate bulk supplier for pharma manufacturers

Nelfinavir Mesylate Suppliers & Bulk Manufacturers

Available Forms: Tablet & Oral Powder

Available Strengths: Tablets: 250 mg, 625 mg: Oral Powder: 50 mg/g

Reference Brands: Viracept®

Nelfinavir Mesylate Tablets (Viracept®) are HIV-1 protease inhibitors used in antiretroviral therapy. Available in 250 mg and 625 mg strengths, they can be sourced in bulk via PharmaB2B from WHO-GMP suppliers. Ideal for HIV programs, tenders, and NGOs seeking alternative, quality-assured ARV treatments.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Nelfinavir Mesylate Tablets, marketed under the brand Viracept®, are antiretroviral medications classified as protease inhibitors used in the treatment of HIV-1 infection. Each tablet typically contains 250 mg or 625 mg of Nelfinavir. Though less commonly prescribed today due to newer agents, Nelfinavir remains essential in select HIV programs and resource-limited settings. On PharmaB2B platforms, global buyers can source WHO-GMP or USFDA-compliant formulations from certified manufacturers and exporters. Ideal for tenders, NGO procurement, and specialty HIV care, Nelfinavir supports access to alternative HIV treatment options. Connect with reliable suppliers to ensure quality-assured antiretroviral availability.

Nelfinavir Mesylate — third party manufacturing & bulk supply

Nelfinavir Mesylate is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Nelfinavir Mesylate is supplied as Tablet & Oral Powder — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Nelfinavir Mesylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Nelfinavir Mesylate →

Back to Listing

Frequently Asked Questions

Nelfinavir mesylate is used to treat HIV-1 infection. It works by inhibiting the HIV protease enzyme, reducing viral replication and helping control the infection as part of combination antiretroviral therapy.

It is made from the active pharmaceutical ingredient nelfinavir mesylate, which is the mesylate salt form of the protease inhibitor nelfinavir.

The well-known trade name is Viracept.

Viracept has been manufactured by Agouron Pharmaceuticals, later acquired by Pfizer, and is also produced by various generic manufacturers globally.

The generic name is nelfinavir mesylate.

The primary brand name is Viracept.

It is manufactured in multiple approved pharmaceutical facilities worldwide, including the USA, Europe, and India, depending on the brand and regulatory requirements.